• xxx


Dr Anna Minchom is a Consultant Medical Oncologist and BRC Clinical Scientist in the Lung Unit at the Royal Marsden Hospital and the Drug Development Unit at the Royal Marsden Hospital and the Institute of Cancer Research. She is a team leader of the Thoracic Oncology Drug Development team and associate honorary faculty at the Institute of Cancer Research.

Dr Minchom completed undergraduate medical training in the University of Wales College of Medicine, qualifying in 2003 and was awarded FRCP in 2022. She trained in medical oncology at the Royal Marsden Hospital during which time completed research investigating mechanisms of resistance to targeted drugs in non-small cell lung cancer, for which she was awarded an MD(res).

She is a Principal Investigator and Chief Investigator on early phase drug trials including first-in-human clinical trials and later phase trials. Her main research focus is using a biomarker-driven and translational approach to develop novel drugs and drug combinations for the treatment of patients with lung cancer and mesothelioma.

UK Oncology Forum 2024

The UK Oncology Forum is only open to UK healthcare professionals. By choosing to continue to enter the UK Oncology Forum website, you are confirming that you are a UK healthcare professional.